Acquisition Opportunity Vivaproducts was acquired by Vivara Scientific Holdings in summer 2025 and is planning to expand into Biotech Research markets and add kitting and biotech services. This signals potential cross-sell opportunities to Vivara’s existing portfolio and a need for scalable equipment and consumables to support expanded offerings.

Biotech Expansion With new initiatives in Biotech Research and expanded product offerings for kitting and biotech services, there is a clear avenue to introduce higher volume, high-precision centrifugal concentrators and related consumables to support increased research throughput.

Clinical to Biopharma Vivaproducts has a long-standing footprint serving clinical laboratories, diagnostic manufacturers, and life science researchers. This positions the company to target biopharma manufacturers expanding into clinical-grade workflows, offering compatible concentration and purification solutions that meet stringent quality and compliance standards.

Supply Continuity With a history of dependable supply and responsive customer support, Vivaproducts may be seeking reliable, scalable suppliers for consumables and components to maintain uninterrupted lab operations, presenting an opportunity for value-added service agreements and bulk procurement deals.

Growth Readiness Revenue is in the mid range for a mid-size lab equipment player and the aggressive growth trajectory post-acquisition suggests readiness to scale. This creates openings for sales partnerships, channel integrations, and supported service models to accelerate market penetration in new segments.